PHARMARESEARCH BIO Co., Ltd. (XKON: 217950)

Market Cap	116.55B
Revenue	n/a
Net Income	n/a
Shares Out	4.05M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	424
Average Volume	660
Open	29,250
Previous Close	29,500
Day's Range	29,000 - 29,750
52-Week Range	19,770 - 39,000
Beta	0.51
RSI	38.39
Earnings Date	n/a

About PHARMARESEARCH BIO

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 217950